» Articles » PMID: 33087123

A Qualitative Study of Big Data and the Opioid Epidemic: Recommendations for Data Governance

Overview
Journal BMC Med Ethics
Publisher Biomed Central
Specialty Medical Ethics
Date 2020 Oct 22
PMID 33087123
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The opioid epidemic has enabled rapid and unsurpassed use of big data on people with opioid use disorder to design initiatives to battle the public health crisis, generally without adequate input from impacted communities. Efforts informed by big data are saving lives, yielding significant benefits. Uses of big data may also undermine public trust in government and cause other unintended harms.

Objectives: We aimed to identify concerns and recommendations regarding how to use big data on opioid use in ethical ways.

Methods: We conducted focus groups and interviews in 2019 with 39 big data stakeholders (gatekeepers, researchers, patient advocates) who had interest in or knowledge of the Public Health Data Warehouse maintained by the Massachusetts Department of Public Health.

Results: Concerns regarding big data on opioid use are rooted in potential privacy infringements due to linkage of previously distinct data systems, increased profiling and surveillance capabilities, limitless lifespan, and lack of explicit informed consent. Also problematic is the inability of affected groups to control how big data are used, the potential of big data to increase stigmatization and discrimination of those affected despite data anonymization, and uses that ignore or perpetuate biases. Participants support big data processes that protect and respect patients and society, ensure justice, and foster patient and public trust in public institutions. Recommendations for ethical big data governance offer ways to narrow the big data divide (e.g., prioritize health equity, set off-limits topics/methods, recognize blind spots), enact shared data governance (e.g., establish community advisory boards), cultivate public trust and earn social license for big data uses (e.g., institute safeguards and other stewardship responsibilities, engage the public, communicate the greater good), and refocus ethical approaches.

Conclusions: Using big data to address the opioid epidemic poses ethical concerns which, if unaddressed, may undermine its benefits. Findings can inform guidelines on how to conduct ethical big data governance and in ways that protect and respect patients and society, ensure justice, and foster patient and public trust in public institutions.

Citing Articles

On the estimation of population size-A comparison of capture-recapture and multiplier-benchmark methods.

Wang J, Kline D, White L Stat Methods Med Res. 2024; 33(10):1818-1835.

PMID: 39350602 PMC: 11827169. DOI: 10.1177/09622802241275413.


Public Involvement and Engagement in Big Data Research: Scoping Review.

Teodorowski P, Jones E, Tahir N, Ahmed S, Rodgers S, Frith L J Particip Med. 2024; 16:e56673.

PMID: 39150751 PMC: 11364952. DOI: 10.2196/56673.


Benefits and challenges of geographic information systems (GIS) for data-driven outreach in black communities experiencing overdose disparities: results of a stakeholder focus group.

Banks D, Paschke M, Ghonasgi R, Thompson V BMC Public Health. 2024; 24(1):2103.

PMID: 39098915 PMC: 11299267. DOI: 10.1186/s12889-024-19541-3.


Building public trust and confidence in secondary use of health data for healthcare improvement and research: a qualitative study pre-protocol.

Bedenik T, Cahir C, Bennett K HRB Open Res. 2024; 6:47.

PMID: 38947251 PMC: 11214037. DOI: 10.12688/hrbopenres.13711.2.


Development of a Real-Time Dashboard for Overdose Touchpoints: User-Centered Design Approach.

Salvi A, Gillenwater L, Cockrum B, Wiehe S, Christian K, Cayton J JMIR Hum Factors. 2024; 11:e57239.

PMID: 38861717 PMC: 11200046. DOI: 10.2196/57239.


References
1.
Weissman M . Big Data Begin in Psychiatry. JAMA Psychiatry. 2020; 77(9):967-973. DOI: 10.1001/jamapsychiatry.2020.0954. View

2.
Kiang M, Basu S, Chen J, Alexander M . Assessment of Changes in the Geographical Distribution of Opioid-Related Mortality Across the United States by Opioid Type, 1999-2016. JAMA Netw Open. 2019; 2(2):e190040. PMC: 6484620. DOI: 10.1001/jamanetworkopen.2019.0040. View

3.
Case A, Deaton A . Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proc Natl Acad Sci U S A. 2015; 112(49):15078-83. PMC: 4679063. DOI: 10.1073/pnas.1518393112. View

4.
Aitken M, de St Jorre J, Pagliari C, Jepson R, Cunningham-Burley S . Public responses to the sharing and linkage of health data for research purposes: a systematic review and thematic synthesis of qualitative studies. BMC Med Ethics. 2016; 17(1):73. PMC: 5103425. DOI: 10.1186/s12910-016-0153-x. View

5.
Formica S, Apsler R, Wilkins L, Ruiz S, Reilly B, Walley A . Post opioid overdose outreach by public health and public safety agencies: Exploration of emerging programs in Massachusetts. Int J Drug Policy. 2018; 54:43-50. DOI: 10.1016/j.drugpo.2018.01.001. View